Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Blaze Bioscience Inc. 

P.O. Box 61323

Seattle  Washington   98141-6323  U.S.A.
Phone: n/a Fax: n/a



 Company News
Blaze Bioscience Inc. Appoints Jan Öhrström, M.D., To Its Board Of Directors 4/1/2015 12:26:27 PM
Blaze Bioscience Inc. Announces Poster Presentation At The American Academy of Dermatology 73rd Annual Meeting 3/18/2015 10:14:21 AM
Blaze Bioscience Inc. Announces National Cancer Institute SBIR Phase II Funding For Clinical Trial Of Tumor Paint™ BLZ-100 In Sarcoma 10/8/2014 10:10:04 AM
Blaze Bioscience Inc. Announces Initiation Of Phase 1b Brain Cancer Program For Tumor PaintTM BLZ-100 9/25/2014 11:32:39 AM
Blaze Bioscience Inc. Announces Presentation At The 2014 Wedbush Pacgrow Life Sciences Management Access Conference 8/13/2014 8:02:52 AM
Blaze Bioscience Inc. Announces Initiation Of First-In-Human Phase 1 Clinical Study Of BLZ-100 12/19/2013 9:45:40 AM
Startup Blaze Bioscience Inc. Nabs $9 Million To Help "Light Up" Cancer Tissue 12/3/2013 7:27:39 AM
Blaze Bioscience Inc. Ropes in $8.1 Million for Tumor Targeting "Paint" 7/3/2013 7:13:55 AM
Blaze Bioscience Inc. Announces Two Poster Presentations at AACR-SNMMI Conference and Award of NCI SBIR Contract Advancing Tumor PaintTM Technology 2/27/2013 6:31:47 AM
Blaze Bioscience Inc. Brings Total Investment to $9.8 Million 2/22/2013 6:46:51 AM